The first immunizations against COVID-19 in the United States are to begin on 14 December, following the historic first emergency use authorization (EUA) of a vaccine, Pfizer/BioNTech’s BNT162b2.
The messenger RNA vaccine was granted the emergency clearance by the US Food and Drug Administration late on 11 December,...